ecancermedicalscience

Policy

The Repurposing Drugs in Oncology (ReDO) Project

10 Jul 2014
Pan Pantziarka, Gauthier Bouche, Lydie Meheus, Vidula Sukhatme, Vikas P Sukhatme

The Repurposing Drugs in Oncology (ReDO) Project seeks to repurpose well-known and well-characterised non-cancer drugs for new uses in oncology. The rationale for this project is presented, examining current issues in oncological drug development, challenges for health systems, and existing and future patient needs. In addition to discussing the advantages of repurposing, the paper also outlines some of the characteristics used in the selection of drug candidates by this project. Challenges in moving candidate drugs into clinical trial and subsequent practice are also discussed.

Related Articles

Julia Palma, Sofía Aljaro, Daniela Arce, Milena Villarroel, Federico Antillón, Luiz Lopes, Nataly Mercado, Adriana Morais, Andrés Portilla, Leonardo Arana, Guillermo Chantada, Mónica Cypriano, Soad Fuentes, Augusto Pereira, Lourdes Vega, Nubia Zuñiga, Liliana Vásquez, Andrea Capellano, Paola Friedrich
Andres Meraz-Brenez, Enrique Soto-Perez-De-Celis, Roberta Demichelis-Gomez, Leonardo Verduzco-Rodriguez, Arjun Gupta, Meera Ragavan, Fumiko Chino, Haydee Cristina Verduzco-Aguirre
Ruqayya Manzoor, Hijab Shaheen, Ana Farooq, Nazia Rafique, Nuzhat Yasmeen, Junaid Jamshed